FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company in the medical psychedelics space, announced it has received clearance from the U.S.
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
Detroit Decriminalizes Psychedelics
Detroit is the latest to join the growing list of U.S. cities that have decriminalized psychedelic substances.
Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline
Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mescaline?